CAMBRIDGE, Mass., Feb. 27 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. announced today that Jean-Pierre Sommadossi, Ph.D., Idenix's chairman and chief executive officer, will present a corporate overview at the upcoming 26th Annual Cowen & Co. Health Care Conference on Monday, March 6, 2006 at 2:20 p.m. ET at the Marriott Copley Place, Boston, MA.
The live and archived webcast of the presentation can be accessed at http://www.corporate-ir.net/ireye/confLobby.zhtml?ticker=IDIX&item_id=1216202 or under "Calendar of Events" in the Idenix Investor Center at http://www.idenix.com. The archived replay will be available on the Idenix website for two weeks following the presentation.
About Idenix
Idenix Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases. Idenix's current focus is on the treatment of infections caused by hepatitis B virus, hepatitis C virus and human immunodeficiency virus (HIV). Idenix's headquarters are located in Cambridge, Massachusetts and it has drug discovery operations in Montpellier, France and Cagliari, Italy.
Contacts: Idenix Pharmaceuticals, Inc. Amy Sullivan (617) 995-9838 Teri Dahlman (617) 995-9905
Idenix Pharmaceuticals, Inc.CONTACT: Amy Sullivan, +1-617-995-9838, or Teri Dahlman +1-617-995-9905,both of Idenix Pharmaceuticals, Inc.
Web site: http://www.idenix.com/
